Neil Sweig, an analyst with Southeast Research Partners, said getting the acute pain indication is vital for Merck, though the market for the both Celebrex and Vioxx is bigger with arthritis because patients with that condition take pain relievers more often.
Even before the NIH study is off the drawing boards, leading US arthritis specialists are recommending glucosamine to their patients not as a cure, but as something that reduces pain in some people and may ( or may not ) retard the progress of the disease, depending on whether the European study results can be confirmed.
If researchers find out the surgery is clearly beneficial, we should probably be doing it more than we're doing now, Moseley said.
The analysis is an important contribution because the authors deciphered hard-to-interpret studies and provide a useful assessment of the latest research, said Dr. John Klippel, medical director of the Arthritis Foundation.
In the past year, doctors wrote 76.7 million prescriptions for anti-arthritis drugs, according to IMS Health, a research group.
American researchers have been slower to show an interest, which is largely a function of the way things work here with herbal therapies, dietary supplements and other nonpharmaceutical products.
Alfalfa: Used for years as a folk remedy for arthritis, no studies show that it's effective.
On the scientific side, leading researchers paint an expansive picture of the future of osteoarthritis treatment.
If you have osteoarthritis of the knee and you are 20
